SCHEMBL6028900

SCHEMBL6028900

O=C(CSc1ncc(-c2ccccc2)cn1)NC(Cc1ccc(Cl)c(C(F)(F)F)c1)C1CCCNC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 1/20 0.36
P2RX7 Q99572 1/20 0.36
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BTK Q06187 1/20 0.35
LMNA P02545 1/20 0.35
CDK9 P50750 3/20 0.34
CCNK O75909 3/20 0.34
CDK12 Q9NYV4 3/20 0.34
CCNT1 O60563 2/20 0.34
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
CDK7 P50613 2/20 0.34
CCNH P51946 2/20 0.34
MNAT1 P51948 2/20 0.34
MC4R P32245 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6028983 0.91 CDK2 (0.38) GAAMAPK1KMT2ALMNACDK2
SCHEMBL6029187 0.91 MAPT (0.38) MAPTKMT2ALMNACHEK1
SCHEMBL6028919 0.90 CHEK1 (0.39) CDK9CCNT1MC4RNTRK1CHEK1
SCHEMBL6029102 0.89 CHEK1 (0.39) GAAMAPK1KMT2ALMNACCNT1
SCHEMBL6028843 0.88 LMNA (0.38) MAPTMAPK1LMNA
SCHEMBL6030280 0.86 NTRK1 (0.39) MAPTKMT2ACDK9CCNT1MC4R
SCHEMBL6030341 0.85 CHEK1 (0.36) GAAMC4RCHEK1JAK1JAK3
SCHEMBL6029129 0.84 CHEK1 (0.35) GAAMAPTLMNAMC4RCHEK1
SCHEMBL6028338 0.83 CHEK1 (0.40) CCNKCDK12CDK7CCNHMNAT1
SCHEMBL6029595 0.81 NPC1 (0.37) GAAMAPTMAPK1SMN1; SMN2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984643-B2 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists ROCHE PALO ALTO LLC (US) 2006-01-10 US disclosed